✦ LIBER ✦

Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer

✍ Scribed by Meehan, K R; Arun, B; Gehan, E A; Berberian, B; Sulica, V; Areman, E M; Mazumder, A; Lippman, M E

Book ID: 110010926
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 69 KB
Volume: 23
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701632

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-2-activated hematopoietic st

Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates

✍ Meehan, K R; Verma, U N; Cahill, R; Frankel, S; Areman, E M; Sacher, R A; Foelbe 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 196 KB

Idiopathic giant cell myocarditis after

Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy : A case report

✍ Cristina I. Truica; Christian H. Hansen; David F. Garvin; Kenneth R. Meehan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

## BACKGROUND. Interleukin-2 (IL-2) is used in the treatment of solid tumors and hematologic malignancies. Sudden death is a rare complication of IL-2 treatment. ## METHODS. A patient with lymphoma underwent chemoradiotherapy myeloablation and autologous stem cell transplantation. The stem cell

Idiopathic giant cell myocarditis after

Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy: a case report

✍ CI Truica; CH Hansen; DF Garvin; KR Meehan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

A Multicenter Randomized Clinical Trial

A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients

✍ Claudine Isaacs; Rebecca Slack; Edmund Gehan; Karen Ballen; Ralph Boccia; Ellen 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 290 KB

Immunomodulation of early engrafted natu

Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-α in autologous stem cell transplantation

✍ Porrata, L F; Inwards, D J; Lacy, M Q; Markovic, S N 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Interleukin-2 and granulocyte–macrophage

Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

✍ Yee Chung Cheng; Gabriela Rondón; Leah F. Sanchez; John D. McMannis; Daniel R. C 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 210 KB